Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Presented on .

The risk factors for cancer are many and varied, and inherited genetic mutations play a major role in 5 to 10% of all cancers. When these mutations are identified early, patients are able to work with their healthcare providers to take crucial steps toward care and treatment. Many of those affected by genetic cancer syndromes don’t know that genetic testing is an option. Both patients and healthcare providers need the resources and education to know when genetic testing is necessary, based on family history and other risk factors.

Cancer genomics programs, including those at CDC, in state and local health departments, and in national organizations, are working together to conduct surveillance and educate the public and healthcare providers about diagnosis and treatment of hereditary cancer syndromes. These programs also aim to assess and reduce barriers to care, ensuring that all those who should receive genetic counseling and testing have access to the appropriate providers.

In this session of Public Health Grand Rounds, you will hear how public health agencies and organizations are evolving in the face of the rapidly growing field of genomics. You will also hear how one woman’s personal experience with a hereditary cancer syndrome led her to become an advocate for patient and provider education.

Beyond the Data

In this session of Beyond the Data, Dr. John Iskander and Dr. Lisa Richardson discuss how establishing a patient’s family history can help healthcare providers identify genetic mutations that may lead to cancer. Tune in to hear how public health is using education and surveillance to improve identification and treatment of hereditary cancer.

Presented By

Lisa Richardson, MD, MPH
Director, Division of Cancer Prevention and Control
National Center for Chronic Disease Prevention and Health Promotion, CDC
Debra Duquette, MS, CGC
Genomics Coordinator and Program Manager
Michigan Department of Health and Human Services
Lindsay Avner, BA
Founder and CEO
Bright Pink
Muin J. Khoury, MD, PhD
Director, Office of Public Health Genomics,
Division of Public Health Information Dissemination

Center for Surveillance, Epidemiology, and Laboratory Services, CDC

Facilitated By

John Iskander, MD, MPH
Scientific Director
Phoebe Thorpe, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director

Enjoyed this Presentation?

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Sign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Additional Resources

MMWR Express Logo

Continuing Education

This session is available for Continuing Education (CE). Register here using the course information below.

CDC Course Code: PHGR10
CPE UAN (enduring): 0387-0000-16-004-H04-P

For more information, see Grand Rounds Continuing Education.

You May Also Like

Cancer Screening

July 2013, Cancer, Chronic Disease
group of adults

Cancer is the second-leading cause of death in the United States. Screening for different cancers helps find these diseases early when they are easiest to treat. Learn about new ways for public health to increase the rate of evidence-based cancer screening, and to decrease screening rate disparities.

  • Page last reviewed: February 28, 2018
  • Page last updated: February 28, 2018
  • Content source:
    • Office of the Associate Director for Science
    • Page maintained by: Office of the Associate Director for Communication
TOP